Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study.

1. Angelini A, Dragani A, Berardi A, Iacone A, Fioritoni G, Tortolano G. Evaluation of four different methods for platelet freezing. In vitro and in vivo studies. Vox Sang 1992; 62:146-51. 2. Currie LM, Livesey SA, Harper JR, Connor J. Cryopreservation of single-donor platelets with a reduced dimethyl sulfoxide concentration by addition of second-messenger effectors: enhanced retention of in vitro activity. Transfusion 1998; 38:160-7. 3. Currie LM, Lichtiger B, Livesey SA, Tansey W, Yang DJ, Connor J. Enhanced circulatory parameters of human platelets cryopreserved with second-messenger effectors: an in vivo study of 16 volunteer platelet donors. Br J Haematol 1999; 105:826-31. 4. Vadhan-Raj S, Currie LA, Bueso-Ramos C, Livesey SA, Connor J. Enhanced retention of in vitro activity of platelets from recombinant human thrombopoietintreated patients following long-term cryopreservation with platelet-preserving solution (ThromboSol®) and 2% DMSO. Br J Haematol 1999; 104:403-11. 5. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer-PFA100TM. Semin Thromb Hemost 1995; 21(Suppl 2):106-12. 6. Favaloro EJ, Facey D, Henniker A. Use of a novel platelet function analyzer (PFA-100TM) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand’s disease and other disorders. Am J Hematol 1999; 62:165-74. 7. Mammen EF, Comp PC, Gosselin R, et al. PFA-100TM system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998; 24:195-202. 8. Rand ML, Carcao MD, Blanchette VS. Use of the PFA100® in the assessment of primary, platelet-related hemostasis in a pediatric setting. Semin Thromb Hemost 1998; 24:523-9. 9. Borzini P, Lazzaro A, Mazzucco L. Evaluation of the hemostatic function of stored platelet concentrates using the platelet function analyser (PFA-100TM). Haematologica 1999; 84:1104-9. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study